Inogen (INGN) EBT Margin Growth (3y) (2016 - 2026)
Inogen (INGN) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 329.00 |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | 1,794.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,794.00 |
| Dec 31, 2025 | -4,074.00 |
| Sep 30, 2025 | 307.00 |
| Jun 30, 2025 | -140.00 |
| Mar 31, 2025 | 978.00 |
| Dec 31, 2024 | 1,555.00 |
| Sep 30, 2024 | -1,415.00 |
| Jun 30, 2024 | -1,960.00 |
| Mar 31, 2024 | -1,578.00 |
| Dec 31, 2023 | -2,866.00 |
| Sep 30, 2023 | -5,140.00 |
| Jun 30, 2023 | -1,707.00 |
| Mar 31, 2023 | -2,590.00 |
| Dec 31, 2022 | 3,710.00 |
| Sep 30, 2022 | -1,849.00 |
| Jun 30, 2022 | -1,680.00 |
| Mar 31, 2022 | -2,414.00 |
| Dec 31, 2021 | -2,572.00 |
| Sep 30, 2021 | -454.00 |
| Jun 30, 2021 | -74.00 |